Effect of Initial Cytoreductive Nephrectomy with Target Therapy versus Target Therapy Alone in Metastatic Renal Cell Carcinoma: A Single Institutional Study
Background: The metastatic renal cell carcinoma (mRCC) patients treated with upfront cytoreductive nephrectomy (CN) combined with immunotherapy results in overall survival (OS) improvement. It is unclear whether mRCC patients treated with target therapy will also benefit from CN. The aim of the s...
Furkejuvvon:
| Váldodahkkit: | , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Dharmais Cancer Hospital - National Cancer Center
2019-05-01
|
| Ráidu: | Indonesian Journal of Cancer |
| Fáttát: | |
| Liŋkkat: | https://www.indonesianjournalofcancer.or.id/e-journal/index.php/ijoc/article/view/635 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|